Bender Robert & Associates’s Pulse Biosciences PLSE Stock Holding History

Bender Robert & Associates’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,190	Closed	-$263K	–	44
2026 Q1	$263K	Buy	+12,190	New	+$225K	0.06%	38
2025 Q4	–	Sell	-11,590	Closed	-$205K	–	44
2025 Q3	$205K	Hold	11,590	–	–	0.04%	44
2025 Q2	$175K	Buy	+11,590	New	+$192K	0.04%	46
2025 Q1	–	Sell	-11,590	Closed	-$202K	–	45
2024 Q4	$202K	Buy	+11,590	New	+$204K	0.05%	43
2024 Q1	–	Sell	-10,325	Closed	-$126K	–	48
2023 Q4	$126K	Hold	10,325	–	–	0.03%	48
2023 Q3	$41.6K	Hold	10,325	–	–	0.01%	47
2023 Q2	$74.2K	Buy	+10,325	New	+$66K	0.02%	48
2021 Q2	–	Sell	-8,825	Closed	-$209K	–	51
2021 Q1	$209K	Buy	+8,825	New	+$264K	0.07%	53

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCM

Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bender Robert & Associates's PLSE Position: Q2 2026 in Review

Bender Robert & Associates sold out of Pulse Biosciences (PLSE) in Q2 2026, closing a stake of 12,190 shares — an estimated $263K sold.

Bender Robert & Associates first reported a position in PLSE in Q1 2021 and held it in 8 quarters. The position peaked at $263K in Q1 2026. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

Bender Robert & Associates reported no remaining Pulse Biosciences position as of Q2 2026 after selling out during the quarter.
Bender Robert & Associates sold 12,190 Pulse Biosciences shares in Q2 2026, an estimated $263K.
Bender Robert & Associates first reported a position in Pulse Biosciences in Q1 2021 and held it in 8 quarters.
Bender Robert & Associates's Pulse Biosciences position peaked at $263K in Q1 2026.
106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Bender Robert & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.